<--- Back to Details
First PageDocument Content
Endocrine system / Diabetes mellitus type 1 / SLC5A2 / Insulin / GLUT4 / Biomarker / Regulatory T cell / Autoimmunity / Interleukin / Biology / Medicine / Diabetes
Date: 2014-09-25 00:19:36
Endocrine system
Diabetes mellitus type 1
SLC5A2
Insulin
GLUT4
Biomarker
Regulatory T cell
Autoimmunity
Interleukin
Biology
Medicine
Diabetes

Add to Reading List

Source URL: www.som.uq.edu.au

Download Document from Source Website

File Size: 33,53 KB

Share Document on Facebook

Similar Documents

Endocrine system / Diabetes mellitus type 1 / SLC5A2 / Insulin / GLUT4 / Biomarker / Regulatory T cell / Autoimmunity / Interleukin / Biology / Medicine / Diabetes

DOCX Document

DocID: 17hG7 - View Document

Chemistry / Dapagliflozin / SLC5A2 / Diabetes management / Insulin resistance / Anti-diabetic medication / Glycated hemoglobin / Sulfonylurea / Phlorizin / Diabetes / Endocrine system / Medicine

CLINICAL SGLT2 inhibition with dapagliflozin Gary Kilov Stephen Leow

DocID: 1465v - View Document

Endocrine system / Chemistry / Gastroenterology / Sitagliptin / Incretin / SLC5A2 / Astellas Pharma / Diabetes management / Sodium-glucose transport proteins / Dipeptidyl peptidase-4 inhibitors / Anti-diabetic drugs / Amides

Microsoft Word - final_150414_e.docx

DocID: 13VvB - View Document

Hoffmann-La Roche / Pharmaceutical sciences / Organic chemistry / Sanofi / Diabetes management / Pharmaceutical industry / Diabetes mellitus / Pitavastatin / SLC5A2 / Chemistry / Diabetes / Chugai Pharmaceutical Co.

License Agreement of SGLT2 Inhibitor “CSG452” in Japan

DocID: ZwJo - View Document

Health / Dapagliflozin / Diabetes mellitus / Anti-diabetic medication / Insulin / Hyperglycemia / SLC5A2 / European Medicines Agency / Diabetes / Endocrine system / Medicine

Forxiga_12_04_PR_antidiabetic

DocID: RJQ3 - View Document